首页> 外国专利> METHOD FOR DETERMINING differential prescription of oral anticoagulants in patients with acute coronary syndrome without ST-segment elevation

METHOD FOR DETERMINING differential prescription of oral anticoagulants in patients with acute coronary syndrome without ST-segment elevation

机译:测定无ST段抬高的急性冠脉综合征患者口服抗凝剂的差异处方的方法

摘要

method u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 differential u043du0430u0437u043du0430u0447u0435u043du0438u00a0 oral u0430u043du0442u0438u043au043eu0430u0433u0443u043bu00a0u043du0442u043eu0432 patients with acute u043au043eu0440u043eu043du0430u0440u043du044bu043c syndrome without st segment elevation, u0437u0430u043au043bu044eu0447u0430u044eu0449u0438u0439u0441u00a0 is h then the patient u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 level of international normalized u043eu0442u043du043eu0448u0435u043du0438u00a0 (non-governmental organization) in blood serum, concentration of u0440u0444u043cu043a in one day u043bu0435u0447u0435u043du0438u00a0 are by the function f, equal x1 + a * h2 + b * x3, the u04451 = 14677, h2 = - 162926, x3 = 0.63.and the importance of the non-governmental organization on admission, b concentration value u0440u0444u043cu043a in one day u043bu0435u0447u0435u043du0438u00a0 and u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 risk u043fu043eu0432u044bu0448u0435u043du0438u00a0 concentration u0440u0444u043cu043a after the abolition of heparin on forms ule;where r is the u0432u0435u0440u043eu00a0u0442u043du043eu0441u0442u044c u043fu043eu0432u044bu0448u0435u043du0438u00a0 concentration u0440u0444u043cu043a after withdrawal of heparin, e (the base of natural u043bu043eu0433u0430u0440u0438u0444u043cu0430) = 2718;;the f - value functions, equal u04451 + a * h2 + b * x3 in u04451 = 14677, h2 = - 162926, x3 = 0.63, and the importance of the non-governmental organization on admission, b concentration value u0440u0444u043cu043a in one day u043bu0435u0447u0435u043du0438u00a0 and the importance of u04400, 5 note that the risk u043fu043eu0432u044bu0448u0435u043du0438u00a0 concentration u0440u0444u043cu043a and given oral u0430u043du0442u0438u043au043eu0430u0433u0443u043bu00a0u043du0442u044b and of r 0.5 note the lack of risk u043fu043eu0432u044bu0448u0435u043du0438u00a0 u043au043eu043du0446u0435u043du0442 the radio u0440u0444u043cu043a and oral u0430u043du0442u0438u043au043eu0430u0433u0443u043bu00a0u043du0442u044b don't ask.
机译:方法 u043e u043f u0440 u0435 u0434 u0435 u043b u0435 u043d u043d u0438 u00a0差分 u043d u0430 u0437 u043d u0430 u0447 u0435 u0435 u043d u0438 u00a0口服 u0430 u043d u0442 u0438 u043a u043e u0430 u0433 u0443 u043b u00a0 u043d u0442 u043e u0432患有急性 u043a u043e u0440 u043e u043d u0430 u0440 u0440 u043d u044b u043c综合征的患者st段高程 u0437 u0430 u043a u043b u044e u0447 u0430 u044e u0449 u0438 u0439 u0441 u00a0为h,则患者 u043e u043f u0440 u0435 u0434 u0435 u043b u043b 非标准化组织的血清中u00a0 u044e u0442的国际标准化水平 u043e u0442 u043d u043e u0448 u0435 u043d u0438 u00a0的浓度,一日内的浓度为 u0440 u0444 u043c u043a u043b u0435 u0447 u0435 u043d u0438 u00a0由函数f等于x1 + a * h2 + b * x3, u04451 = 14677,h2 =-162926,x3 = 0.63。非政府组织录取后,b的浓度值 u0440 u0444 u043c u043a在一天内 u043b u0435 u04 47 u0435 u043d u0438 u00a0和 u043e u043f u0440 u0435 u0434 u0435 u043b u00a0 u044e u0442风险 u043f u043e u0432 u044b u0448 u0435 u043d u0438 u00438 u00 u0440 u0444 u043c u043a取消形式ule上的肝素;其中r是 u0432 u0435 u0440 u043e u00a0 u0442 u043d u043e u0441 u0442 u044c u043f u043e u0432 撤回肝素e后u044b u0448 u0435 u043d u0438 u00a0浓度 u0440 u0444 u043c u043a(天然 u043b u043e u0433 u0430 u0440 u0440 u0438 u0444 u043c u0430 = 2718 ;; f值函数等于 u04451 + a * h2 + b * x3,其中 u04451 = 14677,h2 =-162926,x3 = 0.63,以及非政府组织对接纳的重要性,b集中度一天中的值 u0440 u0444 u043c u043a u043b u0435 u0447 u0435 u043d u0438 u00a0和 u04400的重要性,请注意,风险 u043f u043e u0432 u0432 u044b u0448 u0435 u043d u0438 u00a0浓度 u0440 u0444 u043c u043a并给予口服 u0430 u043d u0442 u0438 u043a u043e u 0430 u0433 u0443 u043b u00a0 u043d u0442 u044b并且r <0.5请注意,没有风险 u043f u043e u0432 u044b u0448 u0435 u043d u0438 u00a0 u043a u043e u043d u0446 u0435 u043d u0442收音机 u0440 u0444 u043c u043a和口头 u0430 u043d u0442 u0438 u043a u043e u043e u0430 u0433 u0443 u043b u043b u00a0 u043d u0442 u044b问。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号